Opus Genetics, Inc.
IRD
$0.865
$0.00430.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 11.25% | 247.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.25% | 247.75% | |||
| Cost of Revenue | -11.07% | 3,023.57% | |||
| Gross Profit | 28.76% | -686.42% | |||
| SG&A Expenses | 150.43% | -13.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.67% | 25.81% | |||
| Operating Income | -25.22% | 3.83% | |||
| Income Before Tax | -366.85% | 3.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -366.85% | 3.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -366.85% | 3.08% | |||
| EBIT | -25.22% | 3.83% | |||
| EBITDA | -25.21% | 3.83% | |||
| EPS Basic | -301.98% | 4.26% | |||
| Normalized Basic EPS | 18.34% | 4.26% | |||
| EPS Diluted | -299.07% | 3.56% | |||
| Normalized Diluted EPS | 18.34% | 4.26% | |||
| Average Basic Shares Outstanding | 16.12% | 1.23% | |||
| Average Diluted Shares Outstanding | 16.12% | 1.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||